Atlas Trials

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

Clinical trial NCT02443545 · TERMINATED

Trial details

NCT number
NCT02443545
Sponsor
ApoPharma
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Iron OverloadSickle Cell DiseaseOther Anemias
Start date
2015-05-21
Primary completion
2019-04-30
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.